Trial Information
Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU): a Feasibility Study
Inclusion Criteria:
- One breast fibroadenoma with diagnosis based on:
- Clinical examination
- Ultrasound image
- For women older than 35 years: mammogram with BI-RADS score < 3
- Histologic confirmation by two independent readers
- Fibroadenoma size between 1 cm and 3 cm at its largest dimension (measured by
ultrasound)
Exclusion Criteria:
- Patient pregnant or lactating
- Bi-RADS score > 2 at the mammogram, or microcalcifications within the lesion.
- History of breast cancer or history of laser or radiation therapy to the target
breast
- Breast implants
- Breast cyst
- Fibroadenoma not clearly visible on the ultrasound images (in B mode)
- Patient participating in other trials using drugs or devices
Type of Study:
Interventional
Study Design:
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Reduction of breast fibroadenoma volume at ultrasonography
Outcome Time Frame:
12 months
Safety Issue:
No
Principal Investigator
Roussanka Kovatcheva, M
Investigator Role:
Principal Investigator
Investigator Affiliation:
University Hospital of Endocrinology (USBALE) "Acad. Ivan Penchev"
Authority:
Bulgaria: Bulgarian Drug Agency
Study ID:
HIFU/BG/FA/Jan2011
NCT ID:
NCT01331954
Start Date:
March 2011
Completion Date:
Related Keywords:
- Breast Fibroadenoma
- Fibroadenoma